Monograph Details
|
|
Eye Disorders
> Glaucoma
|
|
RESCULA |
| Manufacturer |
|
Novartis Ophthalmics |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Prostanoid (docosanoid). |
| Generic Name |
|
Unoprostone isopropyl 0.15%; oph soln; contains benzalkonium chloride. |
| Indications |
|
Open-angle glaucoma or ocular hypertension in patients intolerant of, or who have insufficient response to, other agents. |
| Children |
|
Not recommended. |
| Adults |
|
1 drop twice daily. |
| Precautions |
|
Renal or hepatic impairment. Intraocular inflammation. Contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Allow at least 5 minutes between application of other topical ophthalmic agents. |
| Adverse Reactions |
|
Local irritation, change in length of eyelashes, abnormal vision; eyelid, lacrimation, or vitreous disorder; foreign body sensation, blepharitis, cataract, conjunctivitis, corneal lesion, eye hemorrhage, keratitis, photophobia, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent). |
| How Supplied |
|
Soln—5mL |
|
|
|
|
